As Congress enters a crucial period in December 2023, uncertainty looms over the future of health insurance subsidies. President Donald Trump recently stated he does not...
Recent discussions surrounding the Jeffrey Epstein scandal have sparked a range of opinions, highlighting political hypocrisy and the impact of high-profile cases on public sentiment. As...
Sam Bregman, a Democratic candidate for governor of New Mexico, is advocating for a debate with current U.S. Secretary of the Interior, Deb Haaland. Bregman’s push...
Mayor Daniel Lurie has appointed Alan Wong, a seasoned policy veteran and local resident, to fill the vacant District 4 seat on the Board of Supervisors....
Recent discussions among internet users have turned towards some of the most unsettling pages on Wikipedia. Many individuals have expressed their reactions to these entries, describing...
Donald Trump’s latest proposal for a peace deal with Russia has sparked widespread criticism, particularly from European leaders. The former U.S. president’s 28-point plan, which aims...
The ongoing insurance crisis in California is severely impacting the availability of affordable housing. Following a series of catastrophic wildfires, insurance companies have halted new policies...
Diversity, equity, and inclusion (DEI) programs face increasing scrutiny and criticism in the United States, particularly following the University of Virginia’s recent decision to discontinue its...
Zohran Mamdani begins his tenure as the mayor of New York City with a unique opportunity to reshape the city’s transportation landscape within his first 100...
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) have received a consensus rating of “Moderate Buy” from twenty-one analysts currently covering the company, according to MarketBeat Ratings. While...
